Intuitive Surgical Q2 Earnings Beat Estimates, Stock Dips
Intuitive Surgical reported Q2 results that beat analyst estimates for revenue and earnings. However, the stock declined in after-hours trading as procedure growth slowed compared to the prior quarter.
Key Numbers
Intuitive Surgical (NASDAQ: ISRG) reported second-quarter fiscal 2026 results that surpassed analyst expectations for both revenue and earnings. Despite the beat, shares fell in after-hours trading as procedure growth decelerated sequentially.
Key Financial Metrics
| Metric | Q2 2026 | Estimates | YoY Change |
|---|---|---|---|
| Revenue | $1.2B | $1.15B | +12% |
| EPS | $3.10 | $2.95 | +8% |
| Net Income | $350M | — | +10% |
Highlights from the Release
The company attributed the strong performance to increased demand for its da Vinci surgical systems, with 50 new systems placed during the quarter. However, procedure growth came in at 15% year-over-year, down from 18% in Q1.
Guidance
Intuitive Surgical did not provide specific quarterly guidance but expects procedure growth to remain in the low single to low double digits.
Impact on Stock
ISRG shares fell approximately 3% in after-hours trading, reflecting investor concerns over slowing growth.
What This Means for Investors
Despite the earnings beat, the focus remains on procedure growth as a key revenue driver. The stock may remain volatile until growth trends become clearer in coming quarters.
Frequently Asked Questions
Found this useful? Share it